GCWM
MRK icon

Graham Capital Wealth Management’s Merck MRK Stock Holding History

Graham Capital Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19,347
Closed -$1.76M – 91
2022
Q2 		$1.76M Sell
19,347
-474
-2% -$42K 1.55% 21
2022
Q1 		$1.63M Sell
19,821
-672
-3% -$53K 1.45% 27
2021
Q4 		$1.54M Buy
+20,493
New +$1.63M 1.26% 32

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Graham Capital Wealth Management's MRK Position: Q3 2022 in Review

Graham Capital Wealth Management sold out of Merck (MRK) in Q3 2022, closing a stake of 19,347 shares — an estimated $1.76M sold.

Graham Capital Wealth Management first reported a position in MRK in Q4 2021 and held it in 3 quarters. The position peaked at $1.76M in Q2 2022. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

  • Graham Capital Wealth Management reported no remaining Merck position as of Q3 2022 after selling out during the quarter.
  • Graham Capital Wealth Management sold 19,347 Merck shares in Q3 2022, an estimated $1.76M.
  • Graham Capital Wealth Management first reported a position in Merck in Q4 2021 and held it in 3 quarters.
  • Graham Capital Wealth Management's Merck position peaked at $1.76M in Q2 2022.
  • 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on Graham Capital Wealth Management's 13F filing for Q3 2022, filed 10 Nov 2022.